CVS Health Treasury Stock increased by 0.0% to $36.79B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.1%, from $36.82B to $36.79B. Over 3 years (FY 2022 to FY 2025), Treasury Stock shows an upward trend with a 4.9% CAGR.
An increase indicates active share buybacks, which can signal management's confidence in the stock or an effort to return capital to shareholders.
Treasury stock represents the cost of shares that a company has repurchased from the open market and holds in its own tr...
Standard across all public companies; peers in the pharmaceutical sector often use buybacks to manage earnings per share.
treasury_stock| Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $31.86B | $33.93B | $33.83B | $33.84B | $36.77B | $36.92B | $36.81B | $36.82B | $36.74B | $36.85B | $36.78B | $36.79B |
| QoQ Change | — | +6.5% | -0.3% | +0.0% | +8.7% | +0.4% | -0.3% | +0.0% | -0.2% | +0.3% | -0.2% | +0.0% |
| YoY Change | — | — | — | +6.2% | — | +8.8% | +8.8% | +8.8% | -0.1% | -0.2% | -0.1% | -0.1% |